Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IIa trial of dipraglurant in the treatment of focal cervical dystonia

Next Previous
Trial Profile

Phase IIa trial of dipraglurant in the treatment of focal cervical dystonia

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 03 Dec 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dipraglurant (Primary)
  • Indications Torticollis
  • Focus Proof of concept; Therapeutic Use

Most Recent Events

  • 17 Oct 2016 According to an Addex Therapeutics media release, anticipates the availability of data in the second half of 2017.
  • 17 Oct 2016 According to an Addex Therapeutics media release, Buz Jinnah, Director of the Dystonia Coalition and Professor of Neurology at Emory University, will serve as the lead investigator.
  • 17 Oct 2016 According to an Addex Therapeutics media release, this trial is expected to initiate in the fourth quarter of 2016.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top